Device Trial Radar · NCT02228174
Sonography Guided Transcervical Ablation of Uterine Fibroids
Last checked: Nov 20, 2026Latest source record: Feb 11, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
147
Actual
Start
Oct 2014
Primary completion
Oct 18, 2017
Study completion Nov 2019
Sponsor
- Lead sponsor
- GynesonicsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 28, 2014
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- Female only, from 25 years, up to 50 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to establish the safety and effectiveness of the Sonata® System in the treatment of symptomatic uterine fibroids.
Conditions
- Menorrhagia
Interventions
Intrauterine Ultrasound-Guided Radiofreq. Ablation SystemDevice
The Sonata System combines intrauterine ultrasound (IUUS) with radiofrequency (RF) ablation in a single handpiece. Sonata is suitable in an inpatient or outpatient setting, and is intended for diagnostic intrauterine imaging and transcervical treatment of symptomatic uterine fibroids, including those associated with heavy menstrual bleeding(HMB).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Subjects With ≥ 50% Reduction in Menstrual Blood Loss as Assessed by Pictorial Blood Loss Assessment Chart (PBAC)Time frame: Baseline and 12 Months
- Percentage of Subjects Without Surgical Re-intervention for Heavy Menstrual Bleeding Due to Treatment FailureTime frame: 12 Months
Locations
23 sites in 2 countries. Site status is shown where the registry gives one.
Kelly H. Roy M.D. P.C.
Phoenix, Arizona
Advanced Women's Health Institute
Denver, Colorado
Christiana Care Health Services, Inc.
Newark, Delaware
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.